Vaccines - United Kingdom

Global Research & Data Services
April 18, 2011
SKU: GRDS6631232
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
Biopharmaceutical and Vaccine Production Markets   Though biotechnology has created many new therapies and vaccines – including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders – there are still huge  |  read more...
USD 3,995
Global Animal Vaccines Market 2014-2018
9/3/2014 | published by: TechNavio - Infiniti Research Ltd.
About Animal Vaccines Animal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that can cause a particular disease when in their healthy state.  |  read more...
USD 3,000
Global Pneumococcal Vaccines Market : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
Global Pneumococcal Vaccines Market 2014-2018 About Pneumococcal Disease and Its Prevention Pneumococcus (Streptococcus pneumonia), a pathogenic bacterium, is the leading cause of serious illness across the globe. It is the main cause of pneumonia, sinusitis, blood infections,  |  read more...
USD 2,500
Global Meningococcal Vaccines Market : 2014-2018
8/20/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Meningococcal Vaccines 2014-2018 TechNavio recognizes the following companies as the key players in the Global Meningococcal Vaccines: GlaxoSmithKline plc, Novartis AG and Sanofi Pasteur  |  read more...
USD 2,500
Global Hepatitis B Vaccines Market : 2014-2018
8/27/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Hepatitis B Vaccines Market 2014-2018 TechNavio recognizes the following companies as the key players in the Global Hepatitis B Vaccines Market: GlaxoSmithKline plc, Merck &  |  read more...
USD 2,500
Vaccine Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
Vaccine Deals and Alliances of 2013 The Vaccine Deals and Alliances of 2013 provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using  |  read more...
USD 1,495
DNA Vaccines: Technologies and Global Markets
7/1/2014 | published by: BCC Research
DNA Vaccines: Technologies and Global Markets The global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to $305.3 million in 2014, and further to $2.7 billion  |  read more...
USD 6,650
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
7/14/2014 | published by: GlobalData
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to  |  read more...
USD 7,995
China Human Vaccine Industry Report, 2014-2017
8/1/2014 | published by: Research in China
China Human Vaccine Industry Report, 2014-2017 Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release  |  read more...
USD 2,600
VBI Vaccines - Product Pipeline Review - 2014
7/22/2014 | published by: Global Markets Direct
VBI Vaccines - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘VBI Vaccines - Product Pipeline Review - 2014’, provides an overview of the VBI Vaccines’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 654  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!